Colectomy operation

OPER_COLECTOMY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints OPER_TOTAL_COLECTOMY OPER_JFB30 OPER_JFB31 OPER_JFB43 OPER_JFB44	6873
6. Filter based on genotype QC (FinnGen only)	6873

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	OPER_COLECTOMY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	OPER_TOTAL_COLECTOMY\|OPER_JFB30\|OPER_JFB31\|OPER_JFB43\|OPER_JFB44
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Colectomy operation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6873	3295	3578
Unadjusted period prevalence (%)	1.36	1.12	1.58
Median age at first event (years)	66.73	65.42	67.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6054: Matched controls
60538

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

12.2

323.0

725

667

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

+∞

323.0

1581

WX302

NOMESCO Finland

Thoracal epidural anesthesy

16.5

323.0

1646

1342

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

160.2

323.0

527

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

500.3

323.0

865

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

187.7

323.0

593

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

+∞

323.0

444

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

481.0

323.0

610

B01AB05

ATC

enoxaparin; parenteral

4.3

323.0

3233

12716

L01BC06

ATC

capecitabine; oral

19.3

323.0

1233

790

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

332.4

323.0

728

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.8

323.0

1424

3636

L04AX01

ATC

azathioprine; systemic

9.0

323.0

818

1037

K51.5

ICD-10 Finland

Left sided colitis

17.3

323.0

785

516

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.9

323.0

1475

2698

A07EC02

ATC

mesalazine; oral, rectal

8.3

323.0

1015

1434

JN4BD

NOMESCO Finland

Extensive body CT

5.3

323.0

1635

3939

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

23.5

323.0

630

298

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

10.5

323.0

797

861

WX408

NOMESCO Finland

General anesthesy, balanced

3.9

323.0

2707

10428

JFB30

NOMESCO Finland

Right hemicolectomy

+∞

323.0

1999

JFB43

NOMESCO Finland

Left hemicolectomy

+∞

323.0

755

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

332.9

323.0

929

JFH10

NOMESCO Finland

Total colectomy and ileostomy

+∞

323.0

323

TPH07

NOMESCO Finland

Cathetrisation of artery

5.5

323.0

1537

3500

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

323.0

2030

7611

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

21.7

323.0

507

254

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

11.3

323.0

1003

1047

ZXE20

NOMESCO Finland

More than three and less than five hours

4.4

323.0

1712

5026

UJF32

NOMESCO Finland

Coloscopy

9.3

323.0

4009

10561

130

Kela drug reimbursment

Malignant tumour

8.2

323.0

1707

2766

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

194.3

323.0

674

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

323.0

320

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.8

323.0

1296

2031

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

30.5

302.6

411

144

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

193.4

300.7

312

WX402

NOMESCO Finland

General anaesthesia

3.7

293.1

1561

5256

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

+∞

282.5

269

A04AA02

ATC

granisetron; systemic, transdermal

5.7

275.4

862

1703

K51.8

ICD-10 Finland

Other ulcerative colitis

20.9

275.2

418

214

JAH00

NOMESCO Finland

Laparotomy

9.6

275.1

592

675

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

47.0

274.3

338

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

110.7

270.9

295

UJF30

NOMESCO Finland

Ileoscopy through colon

4.3

269.2

1123

3020

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

70.4

267.5

308

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

7.9

265.3

643

892

A07EA02

ATC

hydrocortisone; rectal

10.6

255.5

520

533

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

90.4

247.7

276

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

20.2

246.1

378

199

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

155.2

239.7

253

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

279.6

237.3

241

JN4AD

NOMESCO Finland

Body CT examination

4.4

236.5

957

2474

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.5

233.3

919

2312

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

230.8

795

1736

A07EA06

ATC

budesonide; oral, local oral

7.9

225.6

546

750

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

224.7

903

2311

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

224.0

2366

12167

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

200.9

224.0

232

JFF10

NOMESCO Finland

Loop enterostomy

32.9

219.4

292

B01AB10

ATC

tinzaparin; parenteral

4.5

218.0

855

2132

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

216.5

2541

13763

WZC30

NOMESCO Finland

Teaching

3.3

213.6

1293

4660

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

213.1

1814

8189

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

6.1

210.4

619

1115

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

208.9

2725

15500

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

30.4

207.8

282

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

16.7

207.7

341

215

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

11.7

203.7

391

354

Z93.2

ICD-10 Finland

Ileostomy status

67.8

203.0

235

ZX120

NOMESCO Finland

Intravenous

3.6

196.3

1009

3186

H02AB02

ATC

dexamethasone; systemic

3.5

194.9

1032

3336

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

73.8

193.3

221

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

10.4

192.8

394

403

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

189.7

1097

3788

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.7

186.6

576

1096

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

96.0

184.4

204

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.5

183.6

329

256

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.0

180.7

631

1381

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

93.5

179.3

199

JFF13

NOMESCO Finland

Terminal enterostomy

122.6

176.2

190

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

55.7

175.9

210

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.3

175.1

579

1191

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

8.8

174.7

391

469

K56.7

ICD-10 Finland

Ileus, unspecified

10.1

173.7

360

377

ZXD05

NOMESCO Finland

Urgent procedure

2.3

173.2

2275

12640

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

135.5

172.3

184

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

85.8

170.4

191

JFB00

NOMESCO Finland

Partial resection of small intestine

9.9

169.4

355

379

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

111.0

168.1

183

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

6.4

166.5

463

768

P01AB01

ATC

metronidazole; oral, rectal

2.2

164.0

2582

15477

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.8

163.2

594

1353

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

7.4

160.7

402

574

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

7.7

158.5

386

529

N02BE01

ATC

paracetamol; systemic, rectal

2.7

156.1

5339

44599

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

60.5

154.6

182

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

204.0

153.6

159

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.7

153.5

472

888

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.0

151.2

360

476

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

227.1

150.8

155

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

+∞

150.6

144

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

127.2

149.9

161

K50.1

ICD-10 Finland

Crohn disease of large intestine

13.1

149.7

271

215

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

177.8

149.3

156

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

+∞

145.4

139

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

102.1

144.8

159

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

143.2

944

3513

D75

ICPC

Malignant neoplasm colon/rectum

20.1

143.0

219

113

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

32.8

141.5

188

K50.8

ICD-10 Finland

Other Crohn disease

11.2

141.5

277

259

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.2

139.6

397

675

K50.9

ICD-10 Finland

Crohn disease, unspecified

11.4

139.2

269

245

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

134.7

3003

20186

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

134.2

1469

7286

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

132.3

2184

13017

A02BC02

ATC

pantoprazole; systemic

2.0

131.0

4082

30975

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.9

130.2

584

1612

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.9

128.1

576

1593

JFH11

NOMESCO Finland

Laparoscopic colectomy

+∞

127.5

122

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

7.2

126.0

320

465

JAH01

NOMESCO Finland

Laparoscopy

4.8

124.1

444

985

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

24.3

123.0

177

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

5.0

118.0

405

859

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

11.6

117.4

225

201

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

68.9

117.1

135

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

12.6

115.7

213

175

J01MA02

ATC

ciprofloxacin; systemic

1.9

115.3

2624

17407

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.8

113.7

527

1491

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.3

113.1

454

1128

R4110

NOMESCO Finland

Physiotherapy

2.0

112.7

1829

10661

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

85.8

112.5

126

K56.2

ICD-10 Finland

Volvulus

16.0

111.5

185

119

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

109.6

2500

16503

TJF80

NOMESCO Finland

Ostomy education

10.8

109.6

217

207

K51

ICD-10 Finland

Ulcerative colitis

15.7

109.4

183

120

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.7

108.7

391

870

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

532.1

106.0

105

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

28.3

104.7

144

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

8.5

102.6

232

281

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

4.6

102.0

374

848

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

101.6

1009

4687

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

95.1

101.3

112

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

8.7

100.9

225

266

K50.0

ICD-10 Finland

Crohn disease of small intestine

8.8

100.2

223

263

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

22.5

99.9

147

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

71.8

98.7

113

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

96.8

1107

5494

JAL30

NOMESCO Finland

Omentectomy

10.3

95.9

194

193

L01BB02

ATC

mercaptopurine; oral

13.0

94.1

170

134

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

464.8

92.5

K65.0

ICD-10 Finland

Acute peritonitis

9.1

91.6

199

225

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

17.0

91.6

148

UJG02

NOMESCO Finland

Proctoscopy

5.7

91.0

275

502

K56.0

ICD-10 Finland

Paralytic ileus

9.4

90.6

193

211

JKA20

NOMESCO Finland

Cholecystectomy

4.6

90.4

333

757

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.6

90.2

438

1281

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

88.7

1140

5938

WX704

NOMESCO Finland

Intubation

3.0

88.5

568

2039

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

88.2

686

2774

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

16.7

87.2

142

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

10.4

86.6

174

171

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.1

86.1

247

422

WX600

NOMESCO Finland

Single shot through catheter

8.1

85.6

199

252

JN4CD

NOMESCO Finland

Very extensive body CT

3.7

85.0

401

1144

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

21.1

84.1

126

D94

ICPC

Chronic enteritis/ulcerative colitis

14.1

81.6

142

103

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.5

81.3

302

692

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.7

81.2

376

1055

C18

ICD-10 Finland

Malignant neoplasm of colon

67.4

80.6

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.7

80.5

286

626

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

6.8

80.5

211

320

WX002

NOMESCO Finland

Sedation and analgesia

1.9

78.9

1348

7819

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

77.7

1263

7186

A04AA01

ATC

ondansetron; systemic, rectal

2.9

76.5

516

1903

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

54.3

76.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.0

75.4

254

525

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.4

74.5

383

1169

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.0

73.2

248

516

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

155.9

73.1

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

91.3

73.1

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

20.9

71.4

107

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.7

71.1

333

942

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

71.0

1574

9929

4AA12

NOMESCO Finland

42.0

69.6

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.9

69.5

239

505

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

7.2

69.3

174

248

Z3231

NOMESCO Finland

Registered nurse

1.7

68.8

1718

11229

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

31.8

68.5

JFH96

NOMESCO Finland

Other total colectomy

+∞

67.8

WW500

NOMESCO Finland

Blood transfusion

3.3

67.7

359

1120

ZXE00

NOMESCO Finland

One hour or less

1.6

66.2

2310

16569

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

9.5

66.1

139

149

UJF92

NOMESCO Finland

Capsular endoscopy

5.2

65.9

212

416

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.9

65.4

190

330

UJF34

NOMESCO Finland

Left colonoscopy

10.0

65.1

133

135

K92.1

ICD-10 Finland

Melaena

2.8

65.0

455

1716

J01MA12

ATC

levofloxacin; systemic

1.8

64.5

1227

7319

Z93

ICD-10 Finland

Artificial opening status

22.7

64.5

Z51.5

ICD-10 Finland

Palliative care

2.6

64.5

499

1997

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.3

64.3

204

394

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

14.5

64.2

110

S18

ICPC

Laceration/cut

1.6

64.0

2537

18768

N02AA05

ATC

oxycodone; systemic

1.9

63.1

1042

5909

N02AX02

ATC

tramadol; systemic, rectal

1.6

63.0

2542

18862

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.4

62.9

325

994

Z93.3

ICD-10 Finland

Colostomy status

9.3

61.9

132

145

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

614.4

61.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

5.4

61.9

195

374

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

30.0

61.6

A07EA01

ATC

prednisolone; rectal

11.9

61.6

115

Z3226

NOMESCO Finland

Physiotherapist

1.8

61.4

1164

6920

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.2

60.3

151

215

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

76.5

60.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

60.1

547

2389

R4190

NOMESCO Finland

Nutritional therapy

3.9

59.7

262

701

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

22.6

59.7

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

12.1

58.2

108

C10AC01

ATC

colestyramine; oral

4.0

58.1

242

618

JF2AB

NOMESCO Finland

Colongraphy with X-ray

20.5

57.9

Z2221

NOMESCO Finland

Medical doctor

1.7

57.5

1631

10947

JFF23

NOMESCO Finland

Transversostomy

7.0

57.5

146

212

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

57.2

1992

14130

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

14.5

56.7

3AC01

NOMESCO Finland

6.6

56.6

151

235

1XC07

NOMESCO Finland

22.1

56.6

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.8

56.4

397

1499

D99

ICPC

Disease digestive system other

7.3

56.3

139

194

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

102.7

55.9

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

43.6

55.8

H02AB07

ATC

prednisone; oral

1.9

55.7

913

5136

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.7

55.7

199

438

H02AB06

ATC

prednisolone; systemic

1.5

55.5

2730

21027

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

13.6

54.1

WX110

NOMESCO Finland

Local anesthesy

1.5

54.0

3697

30635

B80

ICPC

Iron deficiency anaemia

4.7

54.0

192

421

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

117.1

53.9

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

42.3

53.8

L01BC59

ATC

trifluridine, combinations; systemic

36.7

53.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

53.8

744

3920

Z43.2

ICD-10 Finland

Attention to ileostomy

30.3

53.7

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

26.7

53.4

H02AB09

ATC

hydrocortisone; systemic

4.3

52.7

205

491

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

52.6

1013

6018

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.8

52.6

103

WX892

NOMESCO Finland

Monitored bed care

2.3

51.1

535

2496

R50.9

ICD-10 Finland

Fever, unspecified

1.9

50.4

838

4729

JFH01

NOMESCO Finland

Laparoscopic colectomy with ileorectal anastomosis

+∞

50.1

JJB10

NOMESCO Finland

Atypcal resection of liver

23.2

49.2

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

8.1

48.8

112

140

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

48.1

1040

6391

E0000UV

ATC

1.5

48.1

2146

15990

176

Kela drug reimbursment

Regorafenib

30.8

48.0

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.4

47.6

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

27.4

47.3

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

241.8

47.0

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

46.9

235

702

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

102.9

46.8

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

18.4

45.7

E86

ICD-10 Finland

Volume depletion

3.5

45.4

221

645

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

59.4

45.3

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

65.5

45.1

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

27.2

45.1

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

231.7

45.0

SPAT1125

SPAT

Stoma care and guidance

4.3

44.9

175

421

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

84.1

44.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

7.6

44.7

107

143

SPAT1262

SPAT

Handing over of treatment supplies

1.7

44.6

1142

7365

369

Kela drug reimbursment

Regorafenib

26.8

44.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

43.8

591

3068

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.5

43.8

214

627

JAH33

NOMESCO Finland

Opening of laparostomy

24.1

43.6

Z31.5

ICD-10 Finland

Genetic counselling

3.0

43.5

262

893

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

43.4

698

3878

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

43.2

394

1714

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.0

42.9

141

285

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.4

42.0

158

367

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

147.7

41.8

R11

ICD-10 Finland

Nausea and vomiting

2.1

41.8

493

2421

JF1BD

NOMESCO Finland

Very extensive small bowel CT

8.3

41.3

113

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

60.4

41.2

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

3.8

41.2

180

481

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.1

41.0

233

761

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

20.5

40.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

40.5

309

1220

WX290

NOMESCO Finland

Other blockade of nerve

1.5

40.3

2036

15427

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

40.3

500

2509

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

66.1

40.1

B01AB04

ATC

dalteparin; parenteral

2.4

40.0

353

1508

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

40.0

320

1300

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

39.7

486

2421

Z2446

NOMESCO Finland

Social worker

2.3

39.6

381

1703

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

13.4

39.3

R10.0

ICD-10 Finland

Acute abdomen

3.1

39.3

223

728

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

390.0

39.1

A04AD12

ATC

aprepitant; systemic

4.0

39.0

162

414

L04AB04

ATC

adalimumab; parenteral

4.4

39.0

147

343

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

17.6

38.8

JFA70

NOMESCO Finland

Suture of small intestine

11.7

38.6

WX882

NOMESCO Finland

High dependency care

3.2

38.2

212

684

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

63.3

38.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.8

37.8

168

456

SPAT1153

SPAT

Removal of sutures

1.5

37.4

1862

14008

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

37.2

190

577

JFF30

NOMESCO Finland

Other colostomy

27.0

37.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

36.5

484

2490

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

35.8

471

2417

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

13.6

35.7

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.6

35.5

127

282

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

349.3

35.0

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

14.5

34.9

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

78.6

34.8

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

4.0

34.6

144

369

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

10.4

34.5

4AB02

NOMESCO Finland

14.6

34.4

L01XE21

ATC

[U] regorafenib; oral

32.4

34.4

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

5.0

34.2

113

231

K83.0

ICD-10 Finland

Cholangitis

4.2

33.7

132

320

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.0

33.5

109

219

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

33.4

140

362

J01DB01

ATC

cefalexin; oral

1.4

33.4

4528

40723

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

28.3

33.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

33.2

971

6431

A07DA03

ATC

loperamide; oral

2.6

33.1

256

1018

WX872

NOMESCO Finland

Intensive care

2.3

33.1

329

1491

A04AA55

ATC

palonosetron, combinations; systemic

3.2

33.0

179

569

JFC10

NOMESCO Finland

Ileotransversostomy

35.2

32.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.5

32.7

183

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

32.5

284

1207

JFB50

NOMESCO Finland

Other resection of colon

12.1

32.3

Z71.8

ICD-10 Finland

Other specified counselling

1.5

32.2

1160

8085

N03AX16

ATC

pregabalin; oral

1.5

32.1

1286

9180

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

31.5

246

985

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

13.6

31.2

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

39.3

31.1

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

14.6

30.9

JAD10

NOMESCO Finland

Repair of incisional hernia

5.7

30.6

161

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

30.5

164

518

4AA33

NOMESCO Finland

31.0

30.3

D50

ICD-10 Finland

Iron deficiency anaemia

3.8

30.2

133

359

L04AC05

ATC

ustekinumab; parenteral

11.3

30.2

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

58.6

30.1

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

29.9

277

1214

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

29.8

414

2165

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

29.7

354

1742

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

155.8

29.7

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.1

29.6

166

541

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

29.5

981

6693

ZXC86

NOMESCO Finland

Use of endoscopic device

7.7

29.4

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

8.4

29.4

D64.8

ICD-10 Finland

Other specified anaemias

3.7

29.2

132

365

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

28.7

381

1955

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.2

28.7

174

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.0

28.7

116

291

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

28.5

290

1328

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

28.3

332

1620

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

28.2

832

5506

SPAT1255

SPAT

Intravenous administration of medicine

1.9

27.8

405

2154

L04AD01

ATC

ciclosporin; systemic

3.5

27.8

132

380

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

5.0

27.3

180

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.1

27.1

173

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

27.1

350

1780

B82

ICPC

Anaemia other/unspecified

2.8

27.0

181

662

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.0

26.9

179

E34.0

ICD-10 Finland

Carcinoid syndrome

12.0

26.9

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

10.3

26.9

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.4

26.9

132

391

A07EC03

ATC

olsalazine; oral

13.1

26.8

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.9

26.8

113

295

JFG26

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to colon

41.4

26.7

8480/3-C18.3

ICD-O-3

Mucinous adenocarcinoma of hepatic flexure of colon

272.2

26.7

K59.3

ICD-10 Finland

Megacolon, not elsewhere classified

27.8

26.6

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

140.6

26.6

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

7.9

26.6

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

11.2

26.5

JEA00

NOMESCO Finland

Appendectomy

2.1

26.5

330

1654

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.0

26.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

5.8

26.3

130

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

7.7

26.1

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.3

25.7

111

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

93.8

25.6

D01

ICPC

Abdominal pain/cramps general

1.7

25.6

521

3106

JJB71

NOMESCO Finland

Laparoscopic resection of liver

28.5

25.3

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

16.8

25.3

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.1

25.2

145

481

K50

ICD-10 Finland

Crohn disease [regional enteritis]

10.5

25.2

D18

ICPC

Change in faeces/bowel movements

3.0

25.1

150

510

WX610

NOMESCO Finland

Patient controlled analgesia

7.0

25.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.8

24.9

108

289

K60.3

ICD-10 Finland

Anal fistula

3.6

24.9

115

325

JF1AD

NOMESCO Finland

Small bowel CT

5.9

24.4

119

RD210

NOMESCO Finland

3.4

23.7

118

354

A05AA02

ATC

ursodeoxycholic acid; oral

3.6

23.5

109

309

D77

ICPC

Malignant digestive neopl other/NOS

7.2

23.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

23.4

161

601

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

24.7

23.0

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.8

23.0

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

22.9

293

1484

JFB40

NOMESCO Finland

Resection of transverse colon

13.0

22.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.5

22.8

181

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

83.7

22.7

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

230.8

22.6

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.6

22.6

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

25.9

22.6

JHA00

NOMESCO Finland

Anal or perianal incision

3.7

22.5

101

279

H01CB03

ATC

lanreotide; parenteral

9.8

22.5

V03AF03

ATC

calcium folinate; systemic

11.8

22.4

JFA76

NOMESCO Finland

Closure of fistula of small intestine

45.2

22.3

K63.2

ICD-10 Finland

Fistula of intestine

13.6

22.2

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

21.9

357

1976

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

9.1

21.5

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

43.5

21.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

21.3

348

1933

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

13.9

21.2

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.2

21.2

111

347

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

7.4

21.1

K51.4

ICD-10 Finland

Inflammatory polyps

33.9

21.1

UJK02

NOMESCO Finland

ERCP

2.5

21.0

170

696

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

8.3

20.8

K91.8

ICD-10 Finland

Other postprocedural disorders of digestive system, not elsewhere classified

17.9

20.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

20.8

266

1349

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

77.1

20.7

A28

ICPC

Limited function/disability NOS

1.5

20.7

885

6337

JWC00

NOMESCO Finland

Reoperation for deep infection in gastroenterological surgery

14.9

20.6

H01CB02

ATC

octreotide; parenteral

8.4

20.6

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

10.3

20.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

20.4

787

5517

K61.0

ICD-10 Finland

Anal abscess

3.4

20.2

290

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.8

20.1

133

486

TPX15

NOMESCO Finland

Removal of vascular injection port

6.0

20.0

JJA20

NOMESCO Finland

Open biopsy of liver

9.4

20.0

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.0

19.9

197

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

8.5

19.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

19.6

256

1308

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

19.5

331

1861

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.7

19.5

231

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.0

19.4

115

393

ZX100

NOMESCO Finland

Oral

3.1

19.2

106

345

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.3

19.1

176

770

D28

ICPC

Limited function/disability (D)

7.1

19.0

L03AA02

ATC

filgrastim; parenteral

2.4

19.0

158

659

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

55.2

18.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

18.9

691

4782

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.8

18.7

121

438

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

18.7

18.6

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

10.3

18.6

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

18.6

159

674

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.2

18.5

193

897

ZX121

NOMESCO Finland

Central venous catheter

7.8

18.5

A79

ICPC

Malignancy NOS

3.1

18.3

318

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

18.3

417

2564

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

18.3

160

685

JAG60

NOMESCO Finland

Reconstruction of abdominal wall using prosthetic material

11.8

18.2

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

11.0

18.1

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

18.1

522

3419

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

8.9

18.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

18.0

1076

8181

8249/3-C17.2

ICD-O-3

Neuroendocrine tumor, grade 2 of ileum

33.0

17.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

17.8

104

352

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.8

17.7

301

1693

LCD00

NOMESCO Finland

Hysterectomy

2.0

17.7

216

1075

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

17.7

1324

10443

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

10.4

17.6

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

36.8

17.6

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

17.6

226

1150

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

12.5

17.6

8244/3-C18.1

ICD-O-3

Mixed adenoneuroendocrine carcinoma of appendix

180.5

17.5

A06AD11

ATC

lactulose; oral

1.4

17.5

810

5878

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

6.3

17.4

JAK03

NOMESCO Finland

Laparotomy and peritoneal irrigation

9.5

17.3

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.3

17.2

151

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

14.8

17.1

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

3170

16939

2.62

321.98

5.8

4.3

—

(4035726)

1439

5057

3.33

319.85

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1673

6440

3.11

318.81

3.9

2.7

umol/l

7.8

9.2

1.66

1504

5606

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4753

26416

3.59

307.65

5.9

4.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3930

5976

14.02

307.65

7.8

3.5

ug/l

9.7

25.6

4.10

3516

4848

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3918

22808

2.67

307.65

3.9

2.8

ug/l

106.0

147.4

15.72

3672

20797

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2279

8188

3.67

307.65

2.7

2.6

17.8

22.5

44.79

2026

6896

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1488

4395

4.04

307.65

2.1

1.6

—

(3022145) Colonoscopy Study observation

2631

6032

6.45

307.65

1.8

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4854

25751

4.01

307.65

10.9

4.7

g/l

33.6

35.1

52.48

4700

23753

(3022948) Iron [Moles/volume] in Serum or Plasma

2465

9431

3.52

307.65

2.7

2.5

umol/l

10.8

12.7

26.53

2353

8683

(3044640) Blood type and Crossmatch panel - Blood

3794

18219

3.42

307.65

3.6

2.5

—

(3033658) Prothrombin time (PT) actual/Normal

3008

14582

2.89

307.65

6.8

4.0

89.7

87.1

6.47

2972

14225

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3064

13880

3.18

307.65

3.4

2.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3240

15121

3.16

307.65

3.0

2.3

mg/l

3.7

3.0

25.74

2893

12817

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1357

2038

8.05

307.65

5.2

3.2

u/ml

483.3

3304.6

1.25

1211

1726

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5051

30241

3.53

307.65

12.3

6.1

umol/l

11.4

11.9

2.22

4939

28656

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1768

5507

3.98

307.65

2.8

2.2

g/l

0.2

2.64

1696

5098

(3014576) Chloride [Moles/volume] in Serum or Plasma

1921

7737

3.06

307.65

11.6

6.7

mmol/l

105.0

104.4

7.58

1891

7559

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2358

8741

3.58

307.65

2.6

2.5

g/l

2.4

2.3

29.72

2267

8050

(3013650) Neutrophils [#/volume] in Blood by Automated count

4876

32443

2.73

307.40

15.6

8.8

e9/l

4.2

0.29

4321

28129

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3277

18214

2.53

300.55

3.6

2.5

u/l

58.4

58.7

0.10

3153

16738

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1445

5284

3.20

298.92

3.3

2.4

u/l

39.9

46.6

0.32

1311

4503

(40768804) Tissue Pathology biopsy report

3740

22524

2.45

281.81

2.8

2.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1046

3319

3.54

270.46

11.4

9.4

—

(3032080) INR in Blood by Coagulation assay

3991

25058

2.41

269.22

10.7

10.2

inr

1.2

1.3

6.89

1085

6983

(3013826) Glucose [Moles/volume] in Serum or Plasma

4918

34431

2.51

251.78

7.8

4.8

mmol/l

6.9

6.8

0.94

4758

32295

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5801

44225

3.00

245.24

15.8

7.5

u/l

86.7

79.5

14.90

5650

41447

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1451

5904

2.85

243.54

10.9

7.5

g/l

113.9

121.0

34.84

1419

5676

(3014111) Lactate [Moles/volume] in Serum or Plasma

1357

5338

2.92

242.45

8.8

6.6

mmol/l

1.3

1.4

1.68

1316

5128

(3016502) Oxygen saturation in Arterial blood

1533

6442

2.78

241.78

10.5

7.1

96.7

95.5

12.45

1493

6185

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

565

1257

4.81

236.71

5.1

3.1

u/ml

108.4

773.4

2.23

513

1152

(3003396) Base excess in Arterial blood by calculation

1607

7162

2.62

223.61

10.2

6.8

mmol/l

0.3

1.1

12.43

1326

5539

(3027801) Oxygen [Partial pressure] in Arterial blood

1609

7199

2.61

221.91

10.2

6.8

kpa

14.0

12.1

34.41

1561

6834

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1609

7202

2.61

221.70

10.2

6.8

kpa

5.1

1.23

1561

6841

(3000991) Gas panel - Venous blood

1274

5078

2.85

220.39

10.7

7.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4350

30010

2.22

212.24

10.0

6.8

mmol/l

1.2

41.49

3798

25210

(3048689) Calprotectin [Mass/mass] in Stool

1378

5962

2.64

201.56

4.4

2.2

ug/g

349.3

148.8

25.30

1191

4642

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2939

17708

2.15

198.84

5.1

3.2

u/l

37.0

35.4

0.31

2826

16692

(42870588) Differential panel, method unspecified - Blood

3123

19507

2.10

189.60

7.4

5.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3978

27219

2.10

188.38

9.4

6.0

mmol/l

1.2

27.87

3746

24506

(3006504) Eosinophils/100 leukocytes in Blood

3872

26235

2.09

188.22

8.3

6.0

2.7

2.9

6.43

3650

24281

(3019069) Monocytes/100 leukocytes in Blood

3886

26385

2.09

187.59

8.5

6.3

8.8

0.20

3663

24521

(3022096) Basophils/100 leukocytes in Blood

3790

25504

2.08

187.36

8.3

6.0

0.6

0.7

4.82

3571

23619

(3042936) Bacteria identified in Isolate by Culture

1685

8304

2.36

184.26

2.7

2.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

3935

26958

2.08

183.92

8.4

6.1

24.7

27.0

29.51

3702

24886

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1005

3862

2.88

183.83

11.6

8.6

0.7

0.49

999

3832

(3020779) Urea [Moles/volume] in Serum or Plasma

1285

5601

2.59

183.60

7.9

7.2

mmol/l

9.7

10.6

3.92

1240

5321

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1894

9837

2.28

182.90

5.2

3.2

mmol/l

0.8

5.27

1797

9116

(3006315) Basophils [#/volume] in Blood

4032

28065

2.06

177.96

8.0

5.7

e9/l

0.0

0.54

3476

23999

(3001604) Monocytes [#/volume] in Blood

4013

27907

2.05

177.30

8.0

5.7

e9/l

0.6

2.78

3454

23846

(3018010) Neutrophils/100 leukocytes in Blood

3866

26560

2.04

176.26

8.1

5.9

60.0

57.9

22.20

3649

24630

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

993

3878

2.82

175.76

11.6

8.5

1.2

1.4

7.98

987

3853

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

879

3217

2.99

175.29

11.2

8.8

mmol/l

23.8

24.3

5.52

863

2980

(3013115) Eosinophils [#/volume] in Blood

4099

28974

2.03

169.91

8.3

5.9

e9/l

0.2

2.56

3577

25140

(3019198) Lymphocytes [#/volume] in Blood

4062

28649

2.02

169.07

8.1

5.8

e9/l

1.8

1.9

0.57

3567

24929

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

656

2184

3.22

153.27

3.1

u/ml

0.3

2.82

364

1251

(3002582) Erythrocytes [#/volume] in Urine

2837

18132

1.96

151.56

3.9

3.4

e6/l

53.2

97.6

2.02

2263

13979

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

327

673

5.05

149.30

5.5

3.2

nmol/l

8.4

15.1

0.36

321

656

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

573

1836

3.31

142.29

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1523

7918

2.19

141.81

6.8

5.8

mmol/l

1.0

0.85

1443

7323

(3027945) Reticulocytes/100 erythrocytes in Blood

1424

7229

2.22

140.58

2.2

2.5

1.8

0.78

1271

6345

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

864

3561

2.63

135.66

8.9

6.9

mmol/l

24.5

24.8

1.83

858

3528

(3030467) Casts [#/volume] in Urine by Automated count

2600

16627

1.91

134.40

3.9

3.3

e6/l

0.6

0.5

1.26

2040

12591

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

28.48

134.11

2.3

2.8

—

(3026782) Osmolality of Urine

1998

11833

1.97

128.85

3.4

2.9

mosm/kgh2o

547.8

547.9

0.00

1766

10029

(3015377) Calcium [Moles/volume] in Serum or Plasma

2959

19995

1.84

126.40

6.5

3.3

mmol/l

2.3

2.4

1.04

2697

17175

(40758558) Short blood count panel - Blood

2283

14252

1.90

125.00

12.3

6.7

—

(3018095) Leukocytes [#/volume] in Urine

3042

20788

1.83

124.79

4.6

3.9

e6/l

128.6

108.7

0.35

2344

14971

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

392

1094

3.74

120.05

5.3

5.1

iu/ml

487.1

2938.8

0.81

154

(36304419) Bacteria [Presence] in Urine

2479

16052

1.85

119.84

3.8

3.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

312

746

4.33

118.24

2.9

2.5

u/ml

154.6

674.5

0.66

306

724

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1874

11168

1.93

116.66

6.8

3.0

mmol/l

2.5

3.50

1718

9712

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

130

129

10.25

115.74

2.8

3.4

mg/l

7.4

7.6

0.13

110

(3003694) ABO and Rh group [Type] in Blood

2247

14296

1.85

113.57

1.4

—

(40768797) Stomach Pathology biopsy report

1426

7837

2.03

111.48

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1652

9573

1.96

110.92

3.4

3.1

e6/l

2.5

2.3

0.43

935

5303

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

476

1595

3.13

109.06

2.8

2.5

g/l

3.7

3.6

0.68

460

1513

(3018418) pH of Serum or Plasma

2636

17863

1.77

106.24

5.1

4.1

7.4

2.21

510

3385

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

119

118

10.24

105.98

2.2

2.9

au/ml

159.2

65.8

0.99

(3031040) Bacteria [#/volume] in Urine by Automated count

4724

37867

1.79

103.90

5.4

4.8

e6/l

444.3

1877.3

3.46

595

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3398

24941

1.72

101.45

2.3

2.0

pmol/l

91.4

94.4

3.21

2020

12921

(3023520) Reticulocytes [#/volume] in Blood

1067

5464

2.13

99.85

2.3

2.6

e9/l

70.6

68.9

0.72

790

4160

(3037121) Protein [Mass/volume] in Urine

536

2026

2.78

98.62

4.7

3.0

g/l

0.2

0.3

3.26

372

809

(3021589) Normoblasts [#/volume] in Blood

3333

24601

1.69

95.24

16.5

10.0

e9/l

0.0

0.75

2717

20041

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1099

5788

2.07

95.09

5.0

3.8

kpa

5.7

5.8

3.86

1068

5613

(3025941) Bacteria identified in Stool by Culture

680

2940

2.46

95.02

1.5

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1981

12744

1.78

92.71

3.0

2.7

e6/l

5.7

4.9

1.73

1770

11116

(3002032) Base excess in Venous blood by calculation

1089

5766

2.06

92.68

5.0

3.8

mmol/l

1.6

1.9

1.73

872

4678

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

443

1604

2.88

88.14

2.7

2.2

81.4

90.1

10.65

429

1508

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1660

10289

1.81

87.21

3.2

2.9

e6/l

1.1

1.2

0.52

945

5972

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

436

1581

2.88

86.48

1.6

iu/ml

0.1

9.3

1.25

113

365

(3002256) Pathology report gross observation

1295

7468

1.90

85.46

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

415

1476

2.93

85.26

2.9

2.5

214.3

196.6

3.29

404

1405

(3026008) Bacteria identified in Urine by Culture

2570

18207

1.66

82.18

3.6

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6174

55212

2.16

81.41

32.7

15.7

mg/l

35.7

25.1

92.43

5819

44452

(3021960) Folate [Moles/volume] in Serum or Plasma

2126

14411

1.69

80.09

1.7

1.6

nmol/l

21.0

20.2

0.77

1893

12237

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

628

2893

2.29

75.33

5.0

4.0

mmol/l

23.6

24.2

3.66

600

2587

(3037467) Urinalysis macro (dipstick) panel - Urine

4706

39168

1.64

74.71

5.6

4.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

638

3015

2.23

71.85

1.5

1.7

g/l

1.7

1.5

4.45

558

2574

(3007930) Methemoglobin/Hemoglobin.total in Blood

580

2638

2.31

71.58

8.0

4.8

0.9

1.28

554

2466

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1203

7195

1.81

69.19

3.7

4.1

u/l

229.4

246.2

4.40

1140

6763

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1495

9541

1.72

68.61

2.5

2.0

30.2

30.0

0.60

1463

9247

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

576

2664

2.27

68.22

8.0

4.8

1.6

0.57

551

2489

(3024354) Oxygen [Partial pressure] in Venous blood

873

4739

1.96

67.73

4.2

3.2

kpa

4.7

4.5

0.65

842

4574

(3017143) Hepatitis C virus Ab [Presence] in Serum

942

5251

1.92

67.55

1.5

1.6

—

(3036489) Thrombin time

474

2026

2.44

67.24

2.6

2.0

21.6

0.07

444

1792

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3039

23193

1.56

66.90

2.9

2.2

nmol/l

75.0

78.6

10.50

2810

20485

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1554

10100

1.70

66.40

2.0

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

257

821

3.21

63.45

8.5

6.3

mg/l

12.0

0.06

234

753

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

19.73

63.35

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

120

7.50

62.22

2.6

1.8

mg/l

8.2

9.1

0.63

100

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4220

34926

1.54

62.10

4.6

3.1

u/l

67.0

52.5

11.81

3977

32074

(3007853) Bacteria identified in Skin by Aerobe culture

1122

6827

1.77

60.08

2.1

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1770

12224

1.60

58.29

1.8

nmol/l

1148.7

1167.3

0.32

1360

9137

(3019060) Gas panel - Arterial blood

777

4267

1.93

57.73

8.2

4.6

—

(3039000) Anion gap in Blood

351

1408

2.57

56.86

10.9

6.5

mmol/l

11.2

11.3

0.12

330

1255

(3018572) Chloride [Moles/volume] in Blood

351

1409

2.57

56.77

10.9

6.5

mmol/l

106.2

105.0

5.69

330

1256

(3013707) Erythrocyte sedimentation rate by Westergren method

4839

41644

1.55

56.41

5.0

4.2

mm/h

17.0

13.2

39.32

4478

38250

(3007566) Smooth muscle Ab [Titer] in Serum

359

1465

2.53

56.10

1.5

1.2

titre

74.0

139.5

0.78

112

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

8.28

55.55

2.1

1.6

au/ml

117.0

40.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

735

4030

1.92

54.73

11.3

6.8

mmol/l

24.0

24.6

3.58

696

3755

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

327

1291

2.61

54.71

1.7

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6252

57569

1.95

54.69

36.7

18.5

mmol/l

139.1

139.6

54.66

6196

56090

(40768441) Liver Pathology biopsy report

152

378

4.09

54.59

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

997

6014

1.77

54.57

1.5

1.6

—

(3047181) Lactate [Moles/volume] in Blood

433

1949

2.30

54.41

9.7

5.8

mmol/l

1.4

1.3

0.49

393

1717

(3023103) Potassium [Moles/volume] in Serum or Plasma

6257

57690

1.94

53.62

36.8

18.6

mmol/l

4.0

18.06

6193

56114

(3034770) Mitochondria Ab [Titer] in Serum

354

1468

2.49

53.44

1.4

1.2

titre

580.0

1014.0

—

(3002385) Erythrocyte distribution width [Ratio]

5100

44630

1.55

52.97

40.0

19.1

14.6

13.8

154.28

5051

43597

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1706

11958

1.57

51.67

4.1

4.0

ng/l

455.7

503.2

0.10

1413

9856

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

501

2450

2.13

51.25

5.4

3.7

u/ml

79.5

66.7

0.33

487

2349

(3017181) Myelocytes/100 leukocytes in Blood

836

4943

1.79

48.62

4.3

4.1

1.0

0.32

331

1452

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1080

6962

1.65

45.64

1.9

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

511

2669

1.99

43.53

2.3

1.9

ug/l

5.2

2.3

0.52

464

2326

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1069

6953

1.64

43.41

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1692

12236

1.51

43.07

2.2

1.7

mg/l

1.7

1.3

4.11

1396

9414

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5705

51948

1.58

42.44

30.2

14.8

ml/min/173m2

78.1

77.0

3.47

5091

43089

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

376

1773

2.19

42.07

2.0

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

641

3652

1.83

41.87

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

367

1719

2.20

41.75

1.5

1.4

ug/g

243.9

271.9

1.72

236

1032

(3021440) Promyelocytes/100 leukocytes in Blood

779

4707

1.74

41.66

4.4

4.1

0.1

0.2

1.29

305

1357

(40760892) CBC W Ordered Manual Differential panel - Blood

1620

11685

1.51

41.51

5.9

4.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

212

773

2.80

41.43

1.8

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

379

1805

2.16

41.35

4.6

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1389

9704

1.54

41.33

1.6

1.5

g/l

2.7

2.6

1.03

840

5733

(3002179) Metamyelocytes/100 leukocytes in Blood

750

4495

1.75

41.26

4.0

3.9

0.8

0.7

0.78

233

1040

(3044889) 12 lead EKG panel

4574

39927

1.44

41.24

4.5

4.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

207

755

2.80

40.43

1.8

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

207

757

2.79

40.23

1.8

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

654

3793

1.80

40.22

4.1

3.4

g/l

120.4

128.3

13.69

639

3700

(3005988) Vibrio sp identified in Specimen by Organism specific culture

207

760

2.78

39.93

1.8

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

206

756

2.78

39.78

1.8

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

207

764

2.76

39.54

1.8

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

335

1563

2.20

38.46

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

335

1570

2.19

38.04

1.2

—

(3024928) Oxygen saturation in Venous blood

285

1260

2.32

37.23

2.9

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

329

1549

2.18

36.92

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

304

1389

2.24

36.73

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

788

4968

1.66

35.70

2.7

2.2

nmol/l

377.3

373.1

0.21

740

4534

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

415

2166

1.97

35.30

2.7

2.2

ug/l

442.6

615.1

0.53

405

2048

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

135

417

3.28

35.29

1.2

titre

260.0

141.3

1.05

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

135

417

3.28

35.29

1.2

titre

32.0

196.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

631

3766

1.74

34.99

1.8

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

196

4.43

34.71

2.0

1.9

u/ml

6362.3

67639.6

0.62

(3000494) Fungus identified in Specimen by Culture

984

6595

1.57

34.61

1.7

1.4

—

(3025159) Blasts/100 leukocytes in Blood

713

4417

1.69

34.48

4.4

4.1

0.1

0.4

1.74

250

1136

(3028026) IgM [Mass/volume] in Serum or Plasma

554

3236

1.77

33.05

2.1

1.9

g/l

1.5

1.4

0.28

507

2924

(3005719) IgG [Mass/volume] in Serum or Plasma

670

4140

1.69

32.64

2.8

2.7

g/l

11.1

10.5

2.44

616

3757

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

561

3309

1.76

32.34

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

500

2856

1.81

32.14

3.4

2.8

0.7

0.56

493

2735

(3009542) Hematocrit [Volume Fraction] of Blood

5347

48851

1.43

31.29

35.2

16.9

37.3

39.4

44.02

3645

32616

(46235355) HIV 1 and 2 tests - Meaningful Use set

1017

7046

1.52

30.48

1.6

1.7

—

(40761511) CBC panel - Blood by Automated count

6057

56817

1.56

29.97

29.8

15.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

14.26

29.63

1.1

u/ml

22.0

15.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

14.26

29.63

1.1

u/ml

24.4

27.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6202

58524

1.61

29.57

19.8

10.8

u/l

25.7

26.1

0.58

6100

56158

(3009261) Glucose [Presence] in Urine by Test strip

3282

27930

1.34

29.43

4.4

3.9

estimate

0.0

0.11

710

4981

(3024980) IgG subclass 4 [Mass/volume] in Serum

199

834

2.43

29.37

2.0

1.6

g/l

0.9

0.8

0.38

155

627

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1464

10993

1.42

28.83

1.3

1.2

u/ml

2.3

1.9

0.39

354

2823

(3035350) Ketones [Presence] in Urine by Test strip

3232

27528

1.33

28.42

4.3

3.9

estimate

0.0

0.80

697

5074

(3021601) Nitrite [Presence] in Urine by Test strip

3237

27592

1.33

28.24

6.0

5.2

estimate

0.0

0.32

718

5132

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1698

13128

1.39

28.10

1.9

1.7

pmol/l

30216758.5

29887736.9

0.01

1433

10737

(3003181) Sodium [Moles/volume] in Urine

236

1086

2.21

28.05

2.2

1.3

mmol/l

55.9

63.4

1.57

146

882

(3023183) Ammonium ion [Moles/volume] in Plasma

263

1272

2.11

27.56

3.1

2.7

umol/l

31.8

34.7

1.00

237

1068

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

310

1602

1.98

27.10

1.5

1.4

iu/ml

3.1

17.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

226

1037

2.22

27.06

1.4

1.5

pmol/l

188.4

187.8

0.01

220

1008

(3004809) Band form neutrophils/100 leukocytes in Blood

227

1048

2.21

26.77

2.8

3.7

2.4

1.5

1.64

175

791

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

296

1513

2.00

26.69

1.5

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1195

8756

1.44

26.68

24.6

28.0

inr

1.3

1.4

1.83

195

1226

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2764

23180

1.32

26.42

4.2

3.9

ng/l

42.6

78.7

1.04

2132

16987

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

118

410

2.91

25.33

1.8

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

542

3386

1.65

25.12

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

304

3.19

24.21

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

304

3.19

24.21

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

169

721

2.38

24.03

1.2

1.1

g/l

1.5

0.29

163

643

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

119

430

2.80

23.79

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

104

349

3.01

23.77

6.4

3.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

117

421

2.81

23.58

1.6

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

893

6345

1.47

23.18

4.8

3.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

492

3074

1.65

22.75

4.9

3.4

mmol/l

24.7

25.2

2.09

477

2983

(3003327) Ova and parasites identified in Stool by Light microscopy

293

1580

1.89

22.59

1.6

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

389

2287

1.74

22.57

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

237

3.40

22.48

2.8

2.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

383

2261

1.73

21.90

6.5

4.0

mmol/l

1.3

1.4

0.51

376

2221

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

137

560

2.48

21.44

1.6

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

417

2539

1.68

21.29

1.6

u/ml

3.1

21.1

3.87

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

341

1973

1.77

20.92

1.7

1.6

titre

420.0

249.2

0.36

(3015736) pH of Urine

2540

21552

1.28

20.61

3.9

3.6

—

5.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

221

1118

2.01

20.57

4.8

3.8

58.2

0.00

221

1118

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

726

5068

1.48

20.48

4.9

3.9

mmol/l

1.2

1.24

663

4405

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2248

18830

1.29

20.05

3.1

ng/l

1765.9

1652.1

0.38

1949

16285

(3010375) cycloSPORINE [Mass/volume] in Blood

242

3.21

19.73

24.0

25.1

ug/l

129.1

112.2

1.27

196

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

179

860

2.11

19.18

3.2

2.6

u/ml

870.2

2164.2

0.78

(1616796) Gas panel - Central venous blood

254

1391

1.86

18.70

4.0

3.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

447

2869

1.60

18.49

5.9

4.0

46.8

48.2

0.56

439

2834

(3037522) Nuclear Ab [Titer] in Serum

940

7009

1.40

18.43

1.4

1.3

titre

484.8

501.0

0.10

210

1489

(3030981) Hyaline casts [#/volume] in Urine by Automated count

494

3251

1.56

18.34

3.2

2.9

e6/l

0.3

0.26

482

3184

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

372

2.66

17.93

2.2

1.7

—

(4281824)

134

589

2.30

17.90

1.2

—

(3007461) Platelets [#/volume] in Blood

6300

60544

1.49

17.89

47.5

23.1

e9/l

260.5

245.0

47.48

6182

58856

(3012501) Base excess in Blood by calculation

254

1412

1.83

17.84

5.2

4.3

mmol/l

3.0

2.6

0.72

184

969

(3013290) Carbon dioxide [Partial pressure] in Blood

254

1413

1.83

17.80

5.2

4.3

kpa

5.0

0.34

248

1380

(3011648) Oxygen content in Venous blood

113

462

2.47

17.75

2.1

2.3

10.8

10.9

0.08

113

462

(3027315) Oxygen [Partial pressure] in Blood

255

1422

1.82

17.73

5.2

4.3

kpa

9.0

8.5

3.31

249

1388

(3035941) MCH [Entitic mass]

6300

60560

1.48

17.69

47.3

23.0

29.9

30.4

65.62

6252

59551

(3024731) MCV [Entitic volume]

6300

60561

1.48

17.68

47.3

23.0

90.8

91.4

16.64

6254

59552

(3010421) pH of Blood

284

1637

1.77

17.68

5.0

4.2

7.4

0.33

248

1381

(3026361) Erythrocytes [#/volume] in Blood

6300

60565

1.48

17.63

47.5

23.1

e12/l

4.3

4.5

117.42

6160

58667

(3000963) Hemoglobin [Mass/volume] in Blood

6300

60579

1.48

17.46

47.9

23.2

g/l

126.4

134.7

293.17

6252

59584

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

137

3.82

17.46

2.2

2.4

—

(3010813) Leukocytes [#/volume] in Blood

6299

60580

1.48

17.31

47.6

23.1

e9/l

7.2

6.8

21.86

6163

58666

(3028626) Oxygen [Partial pressure] in Capillary blood

250

1400

1.82

17.16

4.0

2.9

kpa

8.1

8.0

0.80

231

1286

(3020393) Adenovirus Ag [Presence] in Stool

5.76

17.09

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

177

888

2.02

16.92

1.2

u/ml

313.4

275.2

0.78

100

545

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

182

931

1.98

16.49

1.4

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

134

612

2.21

16.37

1.3

1.2

u/l

68.3

58.6

0.53

412

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

233

1300

1.82

16.20

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

233

1300

1.82

16.20

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

136

629

2.19

16.12

5.6

3.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

653

4679

1.44

15.95

4.4

3.8

ng/l

108.5

94.4

2.17

580

3968

(3041672) Baker's yeast Ab [Presence] in Serum

10.02

15.80

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

179

926

1.96

15.72

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1743

14491

1.27

15.68

4.7

3.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

957

1.94

15.57

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

248

1434

1.76

15.31

4.5

3.3

mmol/l

1.7

1.6

0.16

242

1398

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

765

5680

1.39

15.23

3.4

2.9

ng/l

219.7

219.5

0.00

693

5199

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

398

2626

1.55

14.61

2.2

1.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

268

1607

1.69

14.54

3.8

3.1

mmol/l

23.6

25.0

4.25

231

1380

(1761482) Bacteria [#/volume] in Urine by Culture

273

1647

1.68

14.47

5.4

4.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

229

1317

1.76

14.42

1.2

—

(3020891) Body temperature

386

2546

1.55

14.19

8.1

4.7

—

(3021901) Oxygen saturation in Capillary blood

207

1170

1.79

13.84

3.1

2.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

339

2.50

13.66

1.4

1.2

u/l

40.0

24.5

1.12

288

(40761536) Microorganisms panel - Urine sediment

649

4786

1.39

13.40

5.3

4.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

131

645

2.05

13.28

2.7

3.7

62.6

58.0

1.46

401

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

366

2424

1.54

13.22

2.0

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

351

2.44

13.18

1.4

1.2

u/l

115.2

89.8

0.91

305

(3022493) Free Hemoglobin [Mass/volume] in Plasma

236

2.77

13.06

5.5

4.6

mg/l

56.2

62.3

0.57

173

(3020630) Protein [Mass/volume] in Serum or Plasma

717

5402

1.37

12.97

2.5

2.6

g/l

65.5

66.2

1.37

655

4850

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

550

3965

1.42

12.94

4.7

3.7

kpa

5.0

5.2

2.82

511

3640

(3011397) Hemoglobin [Presence] in Urine by Test strip

1585

13293

1.25

12.80

3.6

3.9

—

(3013512) EKG study

2043

17623

1.23

12.68

4.7

4.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

523

3769

1.42

12.33

4.6

3.6

mmol/l

1.5

1.8

1.06

368

2792

(3016038) Potassium [Moles/volume] in Urine

407

2.28

12.25

2.5

1.1

mmol/l

35.3

34.4

0.12

346

(3009343) pH of Capillary blood

539

3911

1.41

12.22

4.7

3.7

7.4

0.27

475

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

305

2.48

12.05

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

305

2.48

12.05

1.4

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

224

1348

1.68

12.05

2.6

2.5

15.8

16.1

0.35

122

692

(3033705) Calcium.ionized [Moles/volume] in Venous blood

151

816

1.87

11.74

3.2

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

633

4749

1.37

11.74

4.0

2.6

ml/min/173m2

61.4

63.2

0.58

297

1927

(3038515) Glucose [Moles/volume] in Venous blood

224

1358

1.67

11.72

4.8

3.4

mmol/l

7.6

0.15

219

1329

(3027135) IgG subclass 1 [Mass/volume] in Serum

108

521

2.09

11.62

1.4

1.3

g/l

7.6

6.8

0.98

359

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

361

2.32

11.52

1.9

1.5

u/l

5.3

6.2

0.19

168

(3008757) Leukocyte morphology finding [Identifier] in Blood

130

674

1.95

11.46

2.8

4.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

149

811

1.86

11.34

2.4

1.9

ug/l

16.5

23.6

2.55

143

794

(3035285) Chloride [Moles/volume] in Venous blood

152

833

1.84

11.32

3.2

2.4

mmol/l

104.9

105.7

1.22

152

824

(3041354) Potassium [Moles/volume] in Venous blood

152

833

1.84

11.32

3.2

2.4

mmol/l

4.0

4.1

2.84

152

824

(3024139) IgG subclass 3 [Mass/volume] in Serum

107

520

2.07

11.30

1.4

1.3

g/l

0.5

0.4

0.87

362

(3028192) IgG subclass 2 [Mass/volume] in Serum

107

520

2.07

11.30

1.4

1.3

g/l

3.3

2.8

1.26

362

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

316

2.39

11.19

1.2

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2562

1.48

11.17

2.6

2.3

g/l

3.9

3.8

0.82

266

1799

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3331

30341

1.19

11.15

2.7

2.6

—

(4062490)

107

523

2.06

11.13

1.4

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2565

1.48

11.11

2.6

2.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

294

1930

1.55

11.09

7.3

4.3

mmol/l

3.9

0.38

277

1804

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2567

1.47

11.06

2.6

2.3

g/l

7.7

7.5

1.52

276

1877

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

243

1528

1.61

11.03

4.1

3.0

mg/l

1.8

1.6

1.79

221

1378

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

319

2.37

10.97

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.50

10.93

1.0

—

(3000330) Specific gravity of Urine by Test strip

437

3117

1.43

10.92

5.1

3.6

—

(36660697) Celiac disease serology panel - Serum

536

3961

1.38

10.91

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

308

2065

1.51

10.56

2.5

3.3

ratio

1.4

3.3

1.46

161

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

314

2116

1.51

10.51

2.5

3.3

mg/l

39.9

54.2

1.19

272

1733

(3034860) Kappa light chains.free [Mass/volume] in Serum

314

2120

1.50

10.42

2.6

3.3

mg/l

102.5

82.6

0.22

274

1737

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

2393

1.47

10.37

2.6

2.3

g/l

10.4

10.2

0.28

293

1988

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

237

2.55

10.31

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

172

1015

1.71

10.01

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

124

3.16

9.98

1.6

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

722

5657

1.31

9.94

1.8

1.7

1.5

0.48

619

4880

(3003338) MCHC [Mass/volume]

4791

45268

1.19

9.84

42.4

20.4

g/l

328.9

332.1

87.53

4769

44859

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

343

2386

1.46

9.82

2.6

2.3

g/l

3.2

3.1

0.78

270

1838

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

226

1439

1.59

9.78

1.8

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

149

850

1.77

9.78

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

298

2023

1.49

9.65

1.1

u/ml

11.9

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

154

893

1.74

9.56

1.3

1.4

u/ml

116.7

119.0

0.11

187

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

219

1392

1.59

9.56

1.9

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

106

547

1.95

9.55

1.8

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

209

1315

1.61

9.52

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

162

2.79

9.30

2.5

1.9

—

(3036603) Volume of Urine

397

2.10

9.22

1.7

1938.5

1830.4

0.21

105

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

326

2.22

9.18

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

326

2.22

9.18

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

101

523

1.95

9.03

1.2

1.1

94.3

95.2

0.13

486

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

721

5728

1.29

8.92

2.4

ug/l

5.7

7.3

1.27

626

4924

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

133

2.94

8.90

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

189

2.60

8.88

1.8

1.9

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

8.01

8.86

1.8

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

351

2.12

8.44

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

128

734

1.76

8.32

1.3

1.2

u/ml

3.3

4.4

0.83

308

(3006184) Hemoglobin [Mass/volume] in Capillary blood

215

1410

1.54

8.24

2.3

2.2

g/l

124.5

128.0

1.07

165

1010

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

259

1769

1.48

8.19

2.6

2.2

g/l

0.0

0.63

235

1595

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

188

1201

1.58

8.10

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

121

689

1.77

8.07

1.1

121.1

115.3

1.22

110

610

(3014148) Varicella zoster virus Ab [Titer] in Serum

498

1.90

7.91

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

138

821

1.69

7.89

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

273

1904

1.45

7.78

2.6

2.2

g/l

0.1

0.0

0.40

249

1724

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

132

782

1.70

7.68

1.4

1.3

nmol/l

0.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

282

1984

1.44

7.67

2.6

2.1

g/l

36.3

37.4

2.09

239

1678

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

168

1060

1.60

7.65

1.9

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

217

2.36

7.58

1.6

2.1

e6/l

15253.5

4228.8

0.41

155

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

141

858

1.66

7.43

2.6

3.6

u/ml

19.6

33.6

2.98

135

831

(4268621)

495

1.87

7.41

2.5

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2335

21139

1.16

7.38

4.9

4.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

101

561

1.81

7.36

1.1

—

(3011412) CD3 cells [#/volume] in Blood

507

1.85

7.20

2.3

2.2

e9/l

1.2

1.1

0.31

306

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.55

7.13

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

708

1.71

7.12

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

569

4514

1.28

7.12

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

206

1387

1.50

7.04

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

1741

1.45

7.03

2.6

2.2

g/l

0.0

0.00

233

1590

(3006270) Folate [Moles/volume] in Blood

540

1.81

7.03

1.2

nmol/l

322.1

345.1

0.46

442

(3035320) C reactive protein [Mass/volume] in Body fluid

398

1.95

7.02

2.4

2.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

299

2165

1.40

6.96

2.6

2.3

g/l

0.8

1.0

0.44

259

1836

(3019977) pH of Arterial blood

365

1.98

6.94

3.1

2.4

7.4

0.34

132

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

171

2.47

6.90

1.5

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1752

15591

1.17

6.85

3.1

2.8

umol/l

4426.5

5140.1

0.31

1539

13317

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2049

18455

1.16

6.82

2.3

2.2

u/l

209.9

215.4

0.10

1939

17215

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

300

2.08

6.79

2.5

3.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

114

676

1.70

6.67

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

617

1.73

6.63

3.5

3.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

117

2.74

6.52

1.6

1.1

umol/l

15.2

16.5

0.99

106

(3019225) pH of Specimen

748

6191

1.23

6.50

5.6

4.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.01

6.48

1.7

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

153

2.49

6.41

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.92

6.41

3.1

3.0

ng/l

118.8

148.8

0.18

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

123

755

1.64

6.33

1.3

1.2

u/ml

5.2

3.8

0.36

236

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

135

850

1.60

6.28

2.3

2.2

u/l

2689.6

3791.4

0.18

336

(40760888) Immunoglobulin light chains.free panel - Serum

227

1599

1.43

6.21

2.4

3.5

—

(3044007) Cell count panel - Peritoneal fluid

174

2.36

6.19

1.6

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

113

684

1.66

6.15

1.4

1.3

nmol/l

—

(4306422)

117

716

1.65

6.11

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

498

1.78

6.10

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

193

1323

1.47

6.10

1.1

u/ml

15.8

8.5

0.30

129

(3026250) Tacrolimus [Mass/volume] in Blood

220

2.19

6.07

44.2

33.3

ug/l

6.5

7.5

2.71

198

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

118

726

1.64

6.04

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

162

1077

1.52

5.95

1.4

1.7

nmol/l

0.9

0.8

0.47

141

892

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

112

683

1.65

5.94

1.8

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

344

1.93

5.94

2.3

e6/l

596.3

497.2

0.84

290

(3049717) Cytology report of Urine Cyto stain

339

2572

1.33

5.92

3.0

2.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

438

1.81

5.88

2.2

2.1

34.3

41.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1684

15088

1.15

5.87

4.8

4.3

estimate

0.0

1.98

667

4904

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

192

2.25

5.81

1.6

1.9

e6/l

16061.5

18729.9

0.07

109

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

102

2.75

5.77

5.1

3.0

u/l

64.8

72.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

297

2228

1.35

5.62

1.1

titre

101.4

193.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

289

1.98

5.57

1.2

u/l

287.5

311.2

0.14

263

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

1038

1.50

5.53

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

261

1925

1.37

5.51

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

127

815

1.57

5.50

1.5

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

294

2210

1.35

5.49

2.8

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

456

1.76

5.46

1.8

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

313

1.93

5.42

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

297

1.93

5.18

1.2

1.1

u/l

35.2

32.0

0.10

222

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

297

1.93

5.18

1.2

1.1

u/l

96.2

92.0

0.11

227

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.01

5.16

1.4

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

356

1.83

5.08

2.0

1.8

umol/l

17.3

8.0

0.65

246

(3022313) Gas panel - Capillary blood

361

2833

1.29

4.99

5.1

3.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

845

1.52

4.93

1.8

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

310

1.88

4.91

1.6

1.8

u/field

2.4

2.6

0.08

215

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

375

1.79

4.90

2.1

2.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

214

2.06

4.86

1.9

2.0

ug/l

60.6

57.3

0.18

207

(3020682) Albumin/Creatinine [Ratio] in Urine

2081

19110

1.13

4.84

4.2

4.0

mg/mmol

11.4

9.5

0.88

1430

12070

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

385

1.77

4.80

2.1

2.0

13.5

14.9

0.32

159

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

924

1.49

4.78

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

568

1.63

4.74

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

841

1.51

4.64

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

185

2.11

4.61

1.0

1.1

miu/ml

1674.5

1631.5

0.08

185

(3017732) Neutrophils [#/volume] in Blood

465

3800

1.24

4.59

3.9

3.1

e9/l

4.2

0.33

358

2823

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

171

2374

0.71

4.57

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

421

1.72

4.56

1.4

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

327

1.81

4.49

2.3

2.4

e9/l

0.2

0.47

289

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

507

1.64

4.48

1.7

2.1

u/field

2.2

1.8

0.53

186

(3037756) Immunofixation for Serum or Plasma

193

1407

1.38

4.45

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

372

1.75

4.45

2.1

2.3

e6/l

695.8

584.4

0.45

155

(3011985) Renin [Units/volume] in Plasma

113

745

1.53

4.42

1.5

1.4

mu/l

73.8

57.0

0.45

102

658

(3045716) Anion gap in Serum or Plasma

301

1.83

4.37

2.3

2.1

mmol/l

9.5

9.3

0.13

235

(3042733) HLA Ab [Presence] in Serum

157

2.17

4.32

4.5

4.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

188

1372

1.38

4.32

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

2039

18822

1.12

4.24

3.4

3.2

mmol/l

7.6

7.3

2.06

1723

15661

(3036782) Glucose [Moles/volume] in Pleural fluid

627

1.55

4.17

1.2

1.4

mmol/l

6.7

6.4

0.48

584

(3008295) Osmolality of Serum or Plasma

605

1.56

4.12

1.6

1.3

mosm/kgh2o

276.0

278.4

0.35

460

(44806118)

646

1.54

4.09

1.4

—

(44790048)

646

1.54

4.09

1.4

—

(44790049)

646

1.54

4.09

1.4

—

(44790047)

646

1.54

4.09

1.4

—

(3004451) EKG impression Narrative

323

1.77

4.07

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

302

1.79

4.03

2.3

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

302

1.79

4.03

2.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

302

1.79

4.03

2.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

302

1.79

4.03

2.3

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

149

2.15

4.01

2.3

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

245

1.88

4.00

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

392

1.69

4.00

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

120

821

1.47

3.97

1.3

1.5

e6/l

1834.5

2135.3

0.28

600

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

699

1.51

3.97

1.3

pmol/l

301.8

320.2

0.13

527

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5189

50402

1.12

3.95

4.9

4.8

mu/l

2.1

0.03

4718

45543

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.64

3.92

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

433

1.65

3.90

1.1

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1961

18142

1.11

3.85

3.4

3.3

mg/l

322.7

373.2

0.23

1368

11489

(3027456) Digoxin [Moles/volume] in Serum or Plasma

188

1400

1.35

3.85

3.3

3.1

nmol/l

0.8

0.08

147

1060

(1761868) Lipid panel - Serum or Plasma

1607

17512

0.89

3.84

3.1

—

(3000012) Reticulocyte production index

359

1.71

3.84

1.3

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

624

1.53

3.84

1.9

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

161

2.05

3.70

2.5

2.7

—

(21494755) Public health laboratory ask at order entry panel

281

3519

0.79

3.67

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

657

7573

0.85

3.64

11.4

7.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

106

1531

0.69

3.63

1.7

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

283

1.77

3.62

1.2

1.1

iu/ml

5.0

3.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

1.95

3.61

4.0

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

1.95

3.61

4.0

2.3

—

(3017569) Oxygen content in Arterial blood

332

1.69

3.47

1.6

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

294

3634

0.80

3.44

1.7

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1110

0.64

3.44

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

584

1.51

3.43

1.9

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

153

2.03

3.39

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

160

2.00

3.38

1.2

1.5

g/l

16.4

13.9

1.18

125

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.28

3.35

3.3

1.3

105.5

108.9

0.16

(3028308) Erythrocytes [#/volume] in Pleural fluid

107

744

1.45

3.32

1.3

1.5

e6/l

151839.6

66041.7

0.49

439

(3044242) Glucose [Moles/volume] in Arterial blood

344

1.66

3.32

1.6

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

192

1471

1.31

3.30

2.0

1.9

mg/l

11.6

11.8

0.11

173

1351

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

292

2359

1.25

3.29

2.0

1.8

u/l

39.2

38.6

0.17

255

2044

(3012441) Differential panel - Pleural fluid

104

721

1.45

3.28

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

115

2.18

3.27

1.5

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

561

1.50

3.20

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.58

3.19

1.6

1.4

umol/24h

363.7

355.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

1063

1.36

3.19

4.0

3.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

420

0.45

3.17

1.3

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

260

1.74

3.09

2.0

1.5

ug/l

4.9

4.1

0.15

206

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.44

3.04

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

1.96

3.03

1.3

nmol/l

164.2

124.8

0.42

115

(3003434) Protein [Mass/volume] in Pleural fluid

129

944

1.37

3.03

1.3

1.5

g/l

30.3

31.7

0.61

117

846

(3038071) Oxygen [Partial pressure] in Mixed venous blood

126

2.07

3.01

4.7

8.0

—

(3021788) Differential panel - Synovial fluid

144

1074

1.35

3.00

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

133

2.03

3.00

1.4

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

218

1.79

3.00

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

505

1.51

2.99

1.9

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

113

2.13

2.99

2.1

e6/l

1614.6

772.4

0.22

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

612

1.46

2.97

1.1

u/ml

6.3

2.8

0.49

244

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

1.56

2.92

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

624

1.45

2.89

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

358

1.60

2.88

1.8

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

297

2444

1.22

2.87

5.3

4.0

mmol/l

24.4

24.8

1.52

271

2224

(40768446) Kidney Pathology biopsy report

207

1.79

2.85

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

520

1.49

2.83

2.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

520

1.49

2.83

2.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

520

1.49

2.83

2.0

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

1.82

2.78

2.0

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

605

1.44

2.76

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

239

1.72

2.76

2.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

239

1.72

2.76

2.5

1.9

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.86

2.74

2.6

2.4

pmol/l

3902.8

83.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

122

901

1.36

2.74

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

101

723

1.40

2.74

1.7

1.6

58.0

61.9

0.41

465

(3014051) Protein [Presence] in Urine by Test strip

174

1354

1.29

2.73

2.5

2.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

174

1.84

2.71

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

241

1.71

2.69

2.5

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

894

0.66

2.68

1.5

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

112

2.06

2.66

1.1

pmol/l

1.2

4.8

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.33

2.64

9.5

4.8

ug/min

44.6

54.4

0.35

(3044927) Protein electrophoresis panel - Urine

679

1.40

2.62

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

638

1.42

2.60

1.2

1.3

u/l

273.3

338.4

0.84

608

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

127

1.97

2.59

1.1

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.60

2.57

1.1

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.15

2.55

2.2

5.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

383

0.49

2.52

1.6

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

654

7338

0.88

2.52

4.4

4.7

34.1

32.8

1.86

444

4837

(3022621) pH of Urine by Test strip

450

3897

1.17

2.50

3.3

3.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

478

5476

0.86

2.50

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

270

1.63

2.49

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

357

1.54

2.47

1.9

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.38

2.46

1.4

1.3

ug/l

62.6

127.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

198

1589

1.25

2.45

1.5

g/l

1.2

0.04

190

1499

(3037692) Legionella sp identified in Specimen by Organism specific culture

211

1.71

2.42

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

192

1539

1.25

2.41

1.5

g/l

0.2

0.01

183

1452

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

174

1.79

2.41

2.3

2.0

29.3

29.2

0.01

161

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.00

2.40

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.34

2.39

1.0

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

146

1.85

2.36

4.9

7.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.64

2.36

1.3

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

139

1.87

2.35

1.7

1.3

g/l

30.9

27.4

0.63

109

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

306

0.46

2.35

1.4

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

1.95

2.34

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

452

1.46

2.32

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

308

2604

1.19

2.31

2.2

2.0

—

(3023419) Bacteria identified in Sputum by Culture

105

783

1.35

2.28

3.7

2.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.23

2.27

2.1

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

432

1.46

2.22

1.3

titre

115.7

320.5

—

(3028433) Virus identified in Specimen by Culture

194

1.70

2.22

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

100

2.00

2.20

1.2

mmol/l

2.4

1.9

0.12

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

409

1.47

2.18

1.1

1.0

mg/l

297.1

288.1

0.35

371

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

136

1.84

2.17

1.2

pmol/l

363.0

273.6

0.67

(3026389) Candida sp identified in Specimen by Organism specific culture

100

747

1.34

2.16

1.2

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

418

1.46

2.16

1.3

titre

105.7

63.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

143

1129

1.27

2.08

1.4

u/l

13.0

10.1

1.10

115

916

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

365

1.48

2.06

2.0

1.6

g/l

0.9

1.10

365

(3006245) CD3-CD19+ cells/100 cells in Blood

176

1.71

2.05

2.3

2.0

13.0

10.7

0.28

159

(3045683) HLA typing for celiac disease panel - Blood or Tissue

254

1.58

2.03

1.0

—

(3035880) pH of Pleural fluid

383

1.47

2.03

1.2

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.50

2.01

1.7

1.6

13.6

15.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

357

3098

1.16

1.99

3.5

3.2

pmol/l

4.3

4.4

1.47

316

2707

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

178

1.69

1.98

2.0

u/l

74.9

40.3

0.26

163

(3024471) HLA-A [Type]

156

1.73

1.95

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

233

2765

0.84

1.94

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.55

1.94

1.0

u/field

2.8

1.0

—

(40768443) Skin Pathology biopsy report

306

2635

1.17

1.90

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

173

1414

1.23

1.89

1.4

1.3

iu/l

29.0

30.2

0.17

150

1195

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.31

1.87

2.3

2.0

—

(3024932) HLA-DR beta [Type]

151

1.72

1.86

1.0

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.65

1.86

1.4

pmol/l

18.6

24.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

431

0.60

1.85

1.0

ng/l

46.1

44.0

0.09

285

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

429

0.60

1.82

1.0

ng/l

809.7

723.8

0.41

279

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

198

1649

1.21

1.81

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

428

0.61

1.81

1.0

ng/l

298.4

327.7

0.25

287

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

270

1.52

1.81

1.3

1.5

57.5

66.9

0.90

216

(3022475) Manganese [Moles/volume] in Blood

2.76

1.79

1.7

1.4

—

(3000492) Spirometry study

549

4948

1.12

1.76

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.34

1.74

4.8

8.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

147

1.70

1.73

1.3

1.1

79.1

86.0

0.40

(3034426) Prothrombin time (PT)

170

1.65

1.73

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

191

0.47

1.72

1.4

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

495

0.64

1.72

1.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

148

1.69

1.3

1.2

82.1

84.1

0.08

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

466

1.38

1.69

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

118

1.78

1.69

1.0

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.00

1.69

3.8

4.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.95

1.69

1.2

ng/l

59.9

1064.9

—

(3008898) HLA-B27 [Presence]

173

1436

1.21

1.67

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

281

3235

0.86

1.66

1.3

au/ml

43.6

55.3

0.36

144

(3050129) First trimester maternal screen panel - Serum or Plasma

550

0.67

1.65

1.6

1.4

—

(3016750) Collection duration of Urine

360

1.42

1.62

3.1

2.0

min

526.0

491.6

1.93

256

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

1105

1.24

1.62

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

135

1.71

1.62

2.7

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

278

1.48

1.61

1.7

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.14

1.61

1.8

1.6

umol/l

53.5

40.8

0.35

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

128

1575

0.81

1.60

1.6

1.7

mg/l

4.6

3.8

0.48

1120

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.59

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.50

1.59

1.1

1.0

—

(3014271) Vancomycin [Susceptibility]

370

1.41

1.59

3.3

3.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

312

1.45

1.58

6.1

6.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

460

0.65

1.57

1.7

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

371

1.40

1.57

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

459

0.65

1.56

1.7

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

372

1.40

1.55

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

160

1.63

1.55

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

458

0.65

1.54

1.6

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

256

1.49

1.54

2.7

—

31.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.03

1.54

2.4

2.0

—

(3042631) Mycobacterium sp identified in Specimen

111

888

1.25

1.53

3.4

2.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

457

0.65

1.53

1.6

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.80

1.52

1.2

74.1

76.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

519

1.33

1.52

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

315

3571

0.88

1.52

2.3

2.4

au/ml

17.4

21.5

—

154

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

282

1.46

1.51

1.1

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.59

1.51

1.0

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

375

1.39

1.49

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

375

1.39

1.49

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

375

1.39

1.49

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

101

1.78

1.48

4.4

8.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

1.46

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.77

1.44

1.4

1.2

78.4

74.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

174

1469

1.19

1.44

1.7

1.6

e6/l

13977.7

14488.1

0.06

123

1059

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.13

1.44

2.0

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

220

1.50

1.43

1.4

1.5

1.9

2.6

0.29

181

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.38

1.41

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

120

982

1.23

1.38

1.7

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

407

1.35

1.37

1.4

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

1.58

1.37

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

158

1.58

1.37

2.7

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

688

1.27

1.36

2.1

2.0

—

(3025130) Human papilloma virus identified in Specimen

486

1.32

1.35

1.5

1.7

—

(3004775) Volume in Urine collected for unspecified duration

514

1.31

1.32

2.8

2.2

816.9

638.0

1.31

323

(3028717) Thiamine [Mass/volume] in Blood

1.97

1.32

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

488

1.31

1.32

1.7

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

129

1070

1.21

1.32

1.2

u/ml

2.6

4.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.09

1.30

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

379

0.66

1.29

1.7

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

153

1.57

1.28

1.7

1.5

ug/l

0.4

0.14

(3002619) Bacteria identified in Specimen by Culture

114

1.67

1.28

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

268

1.42

1.27

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

483

1.31

1.26

2.3

—

(40768806) Pleura Pathology biopsy report

723

1.25

1.3

1.6

—

(3005033) Fetal Nuchal fold Thickness US

376

0.66

1.25

1.6

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

244

1.44

1.25

3.1

2.6

—

(4034850)

158

1850

0.85

1.23

12.1

10.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.04

1.22

1.9

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

401

3639

1.11

1.21

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1020

0.80

1.21

1.7

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

180

1.50

1.20

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

615

0.75

1.19

1.3

1.2

mmol/l

8.0

7.6

0.35

443

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.16

0.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

110

1.64

1.15

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

777

1.23

1.15

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

134

1.57

1.14

1.0

1.2

umol/24h

0.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

635

1.25

1.12

3.9

3.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

582

1.26

1.11

1.4

1.3

e6/l

134484.7

105707.0

0.13

405

(3043238) Trisomy 21 risk [Likelihood] in Fetus

389

0.69

1.11

1.6

1.5

—

(3048879) Bone marrow aspiration report

184

1.47

1.10

1.8

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

152

1.51

1.08

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

150

1290

1.17

1.07

1.2

u/ml

4.8

5.3

0.08

129

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

202

1.44

1.07

1.1

1.3

ug/l

300.6

411.5

0.14

102

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

270

2418

1.12

1.07

1.1

—

(3044941) Cell count panel - Synovial fluid

114

958

1.19

1.07

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5223

51583

1.05

1.06

6.5

6.2

mmol/mol

40.8

40.4

2.45

4802

47223

(21494434) Karyotype in Bone marrow

551

1.25

1.05

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

151

1302

1.16

1.05

1.2

u/ml

11.9

7.1

0.26

207

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

275

0.65

1.01

1.1

u/l

1.1

—

140

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.89

1.01

1.5

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.77

1.00

1.8

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

112

948

1.18

0.99

1.4

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.84

0.98

6.1

4.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.84

0.98

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

503

1.25

0.98

1.8

1.6

u/ml

20.2

24.0

0.47

111

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

160

1396

1.15

0.97

1.2

u/ml

37.0

36.9

0.00

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.74

0.96

1.8

2.2

—

(40768800) Prostate Pathology biopsy report

119

1390

0.85

0.96

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5447

53898

1.05

0.95

4.9

mmol/l

6.1

6.0

7.23

4943

48540

(3009871) Measles virus Ab [Titer] in Serum

141

1.49

0.94

1.5

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

141

1.49

0.94

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.77

0.94

1.0

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

133

1.51

0.94

1.1

1.3

mu/l

178.3

67.8

0.47

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

444

1.26

0.93

5.1

4.9

u/ml

40.9

82.1

0.85

130

(3024869) Neuronal Ab [Presence] in Serum

119

0.50

0.93

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

117

1.54

0.93

1.4

1.5

1.7

7.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

217

1.38

0.93

1.8

2.2

umol/l

92.7

145.6

0.85

114

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

331

1.30

0.90

5.1

3.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

176

1.42

0.90

2.0

197.0

190.3

0.10

166

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

179

1584

1.13

0.90

1.7

—

(3006462) Nitrate [Presence] in Urine

279

1.33

0.89

4.1

3.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

474

1.25

0.89

1.4

1.5

nmol/l

0.4

0.3

0.65

357

(3021387) Prolactin [Units/volume] in Serum or Plasma

139

1211

1.15

0.88

1.5

1.7

mu/l

273.4

302.2

0.75

130

1101

(3034891) Synovial lining cells/100 cells in Synovial fluid

280

1.32

0.88

1.5

5.7

3.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

130

0.54

0.87

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.86

0.87

1.9

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4225

41618

1.04

0.85

4.1

3.9

pmol/l

14.8

14.9

3.21

3819

37378

(3013293) Extractable nuclear Ab [Presence] in Serum

1.67

0.85

1.7

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

826

1.18

0.83

1.5

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

129

1.47

0.83

1.3

1.2

mmol/l

1.5

1.6

0.36

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

178

0.62

0.82

1.0

1.2

—

28.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

114

0.53

0.82

4.0

3.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

190

0.63

0.82

1.0

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.88

0.81

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

139

1221

1.14

0.80

1.6

1.8

iu/l

6.6

4.6

0.63

402

(40765096) Chromosome analysis panel by Banding

189

1.38

0.80

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

418

1.25

0.80

1.4

1.3

promille

1.3

1.2

0.29

322

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

329

1.28

0.80

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

106

1.51

0.78

1.2

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

106

1224

0.86

0.78

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

657

1.19

0.77

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

162

0.62

0.76

1.1

—

(3015183) Erythrocyte sedimentation rate

200

1.35

0.76

1.0

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

705

1.18

0.75

9.0

17.2

mmol/l

7.5

7.4

0.11

584

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.64

0.75

2.8

2.5

u/field

0.5

0.01

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

669

1.18

0.75

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.80

0.72

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.80

0.72

4.0

2.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.80

0.72

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.67

0.72

1.0

1.1

—

(4211845)

308

1.27

0.71

4.2

3.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

562

1.19

0.71

1.6

1.5

35.3

28.1

0.79

355

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

125

1103

1.14

0.70

1.2

—

8.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.56

0.68

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.56

0.68

2.9

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.63

0.66

1.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.79

0.66

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5325

53697

0.96

0.66

4.3

4.6

mmol/l

1.4

1.53

4837

48793

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

313

1.25

0.64

2.2

2.6

37.9

37.3

0.05

111

(3035933) Granulocytes/100 leukocytes in Blood

120

1.42

0.64

1.5

1.6

—

(1002224) Polysomnography panel

167

1843

0.90

0.64

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

274

2956

0.92

0.64

1.8

1.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.72

0.64

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.52

0.62

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

103

0.58

0.62

1.2

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

553

1.18

0.62

1.5

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.60

0.61

6.9

4.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

112

1259

0.89

0.60

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.57

0.60

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

5.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.59

0.0

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

307

3283

0.93

0.58

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

701

0.85

0.57

1.1

u/ml

0.2

1.8

4.13

273

(3009466) Valproate [Moles/volume] in Serum or Plasma

764

0.86

0.56

7.3

4.7

umol/l

366.2

351.8

0.39

647

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

793

1.14

0.56

1.2

1.1

iu/ml

142.3

799.6

0.43

170

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

1.40

0.55

1.1

1.2

mg/l

1.2

138.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

366

1.20

0.55

2.0

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

151

1.33

0.53

1.5

ug/l

11.1

9.1

0.85

151

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

160

1.31

0.53

1.4

1.3

28.4

31.7

0.16

107

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

115

1036

1.11

0.51

1.3

u/l

26.2

42.6

2.27

102

898

(4212803)

1.41

0.51

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

342

1.20

0.51

1.3

u/ml

1.0

1.2

0.10

169

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.56

0.48

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

208

1.25

0.47

1.0

1.1

94.2

93.9

0.02

156

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.47

0.47

1.5

—

(4094501)

144

1567

0.92

0.46

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

120

1.33

0.46

1.2

—

260.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

375

1.17

0.45

1.3

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

192

1.25

0.44

1.4

1.2

g/l

36.8

39.5

0.29

100

(3047189) Immunofixation for 24 hour Urine

330

0.82

0.44

2.0

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

286

0.80

0.44

1.0

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

498

1.15

0.43

1.2

1.3

u/l

10.5

12.3

0.64

457

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

230

0.78

0.43

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5383

54153

0.97

0.43

4.4

4.6

mmol/l

4.4

4.6

13.65

4925

49541

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

207

0.77

0.42

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.56

0.42

1.0

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.56

0.42

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.38

0.42

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

623

1.12

0.41

1.2

u/ml

28.4

50.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.52

0.41

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

261

0.80

0.41

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

174.3

—

(3045142) Bone marrow Pathology biopsy report

700

1.12

0.40

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.40

0.0

1.1

—

16.9

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.36

0.40

8.8

12.5

mmol/l

5.7

5.6

0.07

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.1

—

(40757373) Influenza virus identified in Isolate

124

1.29

0.38

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

548

0.88

0.38

1.1

—

2.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

345

0.84

0.38

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.39

0.38

3.8

3.3

—

(3000034) Microalbumin [Mass/volume] in Urine

581

1.12

0.37

4.3

3.0

mg/l

74.2

42.4

0.40

438

(3000764) Benzodiazepines [Presence] in Urine

107

1164

0.92

0.37

2.3

2.0

—

(3020491) Glucose [Moles/volume] in Blood

421

1.14

0.36

1.5

2.2

mmol/l

7.9

6.8

0.87

284

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

309

1.17

0.36

2.5

2.4

—

(4198724)

157

0.76

0.35

1.8

1.7

—

(3017704) Immunofixation for Urine

367

1.15

0.34

1.4

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

255

1.18

0.34

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

109

1177

0.92

0.33

2.3

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

456

0.88

0.33

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

173

1.21

0.32

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

916

0.92

0.32

2.5

2.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

388

1.13

0.32

1.2

1.3

mmol/l

10.4

12.1

0.97

111

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

0.77

0.32

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.32

0.30

1.9

3.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

324

1.14

0.30

2.1

2.2

ug/min

104.2

186.7

—

(3027008) Opiates [Presence] in Urine

109

1171

0.93

0.30

2.3

2.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.33

0.30

1.4

1.2

mg/l

6.3

7.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.27

0.30

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2197

21699

1.02

0.29

4.9

5.2

ug/l

3.0

3.6

0.58

1941

19340

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

525

1.11

0.29

1.2

1.3

nmol/l

1.2

1.5

1.28

464

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

107

998

1.07

0.28

1.2

u/ml

66.2

40.1

0.64

101

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

522

0.90

0.27

1.1

—

54.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.23

0.27

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.23

0.27

1.4

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.23

0.27

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.23

0.27

1.4

1.3

—

(4027681)

279

0.86

0.27

1.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.21

0.26

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

300

1.13

0.26

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

208

1988

1.05

0.26

1.2

u/ml

0.6

1.1

—

195

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

331

3426

0.96

0.25

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

192

0.83

0.25

1.2

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

282

1.14

0.25

1.1

1.2

ratio

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

111

1180

0.94

0.25

1.1

1.3

mmol/l

3.8

0.31

102

1097

(3017446) Testosterone [Moles/volume] in Serum or Plasma

412

4245

0.97

0.25

2.3

2.2

nmol/l

11.3

12.6

2.63

363

3709

(4015189)

179

1.17

0.25

3.0

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

591

0.91

0.24

1.1

u/ml

0.3

1.3

2.31

246

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.18

0.24

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

663

6482

1.03

0.24

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.28

0.24

1.5

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

115

1.22

0.23

1.4

1.2

—

(3027944) Amphetamines [Presence] in Urine

108

1145

0.94

0.23

1.9

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

462

0.91

0.22

1.0

1.1

u/ml

0.7

2.6

—

182

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

9.2

—

60.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1049

0.94

0.21

1.2

1.3

miu/ml

196.2

207.1

0.10

432

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

220

0.86

0.21

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

117

1233

0.95

0.21

1.8

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.16

0.21

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

325

1.11

0.21

1.7

1.5

u/l

5.5

6.5

0.55

274

(40768793) Breast Pathology biopsy report

121

1150

1.05

0.20

1.3

—

(3025315) Body weight

1.25

0.20

7.2

4.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

428

0.91

0.20

1.0

1.1

u/ml

1.7

3.8

—

173

(3016879) Cocaine [Presence] in Urine

103

1087

0.95

0.20

2.3

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

613

0.93

0.19

1.1

u/ml

3.4

4.6

0.35

294

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

838

0.94

0.18

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

766

0.94

0.18

2.2

2.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

1567

1.04

0.18

2.8

2.3

ug/min

104.1

109.2

0.05

918

(3022689) Creatine [Moles/volume] in Urine

174

0.86

0.17

1.9

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

121

1157

1.05

0.17

1.4

e6/l

35.4

26.7

0.19

899

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

905

8921

1.02

0.17

1.3

iu/ml

39.3

35.8

0.22

266

2725

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5172

51883

0.99

0.17

4.0

4.1

mmol/l

1.4

1.3

17.96

4659

46725

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

121

1158

1.05

0.17

1.5

1.4

e6/l

747.2

1317.5

0.47

952

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.17

1.0

1.2

umol/24h

1.9

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.76

0.17

1.0

1.1

—

(3001729) Color of Synovial fluid

0.76

0.17

1.0

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.72

0.16

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.18

0.16

1.8

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.16

0.16

2.3

2.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.13

0.16

2.5

1.6

—

(4133840)

130

0.85

0.16

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

111

1.17

0.15

1.2

—

(44813793)

312

1.09

0.15

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

293

1.09

0.15

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.15

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1218

12311

0.99

0.15

4.3

4.4

kg/l

1.0

0.25

194

1886

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.15

0.15

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

379

0.92

0.15

1.3

1.4

pmol/l

86.2

136.0

0.27

121

(3000285) Sodium [Moles/volume] in Blood

1.18

0.14

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

309

3022

1.02

0.14

1.1

1.2

iu/ml

98.3

139.5

1.54

1089

(4146454)

695

0.95

0.13

2.3

2.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

151

1.13

0.13

1.5

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

111

1069

1.04

0.13

1.5

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

403

1.07

0.13

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1477

14890

0.99

0.13

1.7

1.6

mmol/l

1.5

1.4

3.54

1254

12390

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

130

1343

0.97

0.12

1.2

1.3

mg/l

552.7

544.1

0.05

123

1264

(4010399)

420

4130

1.02

0.12

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

309

3029

1.02

0.12

1.3

u/ml

170.0

240.4

1.72

285

2761

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.18

0.12

8.0

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.18

0.12

4.0

3.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

492

1.06

0.12

1.3

1.4

u/l

33.7

29.2

0.39

403

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1230

12405

0.99

0.12

3.1

ug/l

0.8

0.82

869

8566

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

435

0.94

0.11

1.2

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

848

8398

1.01

0.10

1.3

1.2

u/ml

14.7

13.3

0.18

300

3097

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

115

1.13

0.10

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1727

17373

0.99

0.10

4.2

4.5

21.8

22.1

0.31

868

8830

(3036071) Salmonella sp Ab [Titer] in Serum

154

1.10

0.10

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

799

0.96

0.10

2.3

2.1

mg/l

31.0

24.9

0.40

198

(3002523) Influenza virus A Ag [Presence] in Specimen

604

1.04

0.10

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

604

1.04

0.10

1.1

—

(4024509)

595

1.04

0.09

1.5

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.06

0.09

1.2

1.1

u/ml

—

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

741

7345

1.01

0.08

1.5

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.05

0.08

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

107

1.12

0.08

1.3

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.03

0.08

3.3

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.81

0.08

1.4

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.14

0.08

1.2

nmol/l

19.0

32.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.12

0.07

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

225

1.07

0.07

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.04

0.07

1.1

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

194

0.93

0.07

1.1

1.0

u/ml

1.0

0.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

118

1.10

0.07

2.3

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

285

1.05

0.06

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

386

0.96

0.06

1.0

u/ml

0.1

0.3

—

104

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

148

1.08

0.06

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

121

0.91

0.06

3.3

7.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

119

1.09

0.06

1.2

1.1

—

(40761535) Cells panel - Urine sediment

506

5099

0.99

0.05

3.6

3.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

190

1926

0.99

0.05

1.5

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

326

1.04

0.05

1.1

nmol/l

36.3

6.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

139

1.08

0.05

2.5

2.3

mmol/l

7.4

7.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

346

1.04

0.05

3.7

2.2

umol/l

33.1

30.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

911

1.02

0.05

1.4

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

149

1.07

0.05

1.0

1.1

—

(3012565) Volume of 24 hour Urine

297

1.04

0.05

2.2

2.4

1755.8

1873.1

0.27

251

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

150

1.07

0.04

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

527

1.02

0.04

3.4

2.7

—

(3025577) Chromium [Mass/volume] in Blood

412

0.97

0.03

1.8

2.0

ug/l

1.7

2.2

0.94

349

(44806420)

200

0.95

0.03

2.2

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

200

1.05

0.03

2.3

2.8

umol/l

27.1

29.6

0.35

145

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

280

1.04

0.03

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

642

0.98

0.03

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5538

55412

1.00

0.03

4.9

5.2

mmol/l

2.5

2.7

24.85

5043

50445

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

0.98

0.02

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

203

1.03

0.01

1.0

1.1

u/ml

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

158

1572

1.01

0.01

1.8

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

154

1.04

0.00

1.0

1.1

—

(3024263) Appearance of Synovial fluid

334

1.02

0.00

1.7

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

336

0.98

0.00

17.5

13.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

131

1316

1.00

0.00

4.1

3.7

mg/l

31.1

28.6

0.28

839

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

107

1.03

0.00

2.4

1.6

ng/l

221.4

144.5

0.60

107

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

164

0.98

0.00

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

0.97

0.00

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

131

1305

1.00

0.00

1.4

1.3

—

(3020650) Glucose [Presence] in Urine

128

1.02

0.00

1.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

138

1.01

0.00

1.0

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

538

1.00

0.00

1.1

u/ml

0.9

2.0

—

139

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

141

0.99

0.00

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

141

0.99

0.00

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

141

0.99

0.00

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

141

0.99

0.00

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

141

0.99

0.00

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

181

0.99

0.00

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(44806071)

0.88

0.00

1.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.99

0.00

1.4

2.0

umol/l

11.5

18.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.91

0.00

1.1

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.91

0.00

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.00

0.00

1.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.94

0.00

6.7

11.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1441.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

139.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

39.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.93

0.00

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.97

0.00

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.95

0.00

1.1

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.95

0.00

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.98

0.00

1.0

1.1

—

(3014891) Appearance of Pleural fluid

0.95

0.00

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

0.00

1.0

1.2

u/l

7.8

11.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_COLECTOMY – Colectomy operation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Colectomy operation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Colectomy operation (OPER_COLECTOMY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints